[ad_1] Johnson & Johnson products for sale in New York. Scott Mlyn | CNBC Johnson & Johnson will price shares of its consumer-health spinoff Kenvue at $20 to $23 in an initial public offering later this year, the company said in a regulatory filing Monday. The spinoff, which would be valued at around $40 billion…
[ad_1] Johnson & Johnson logo SOPA Images | LightRocket | Getty Images Johnson & Johnson‘s consumer health business is valued at $40 billion ahead of its initial public offering later this year, according to a report by The Wall Street Journal. The soon-to-be spinoff Kenvue aims to raise $3.5 billion or more in the offering,…
[ad_1] In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. Justin Sullivan | Getty Images A federal bankruptcy judge on Thursday halted roughly 40,000 lawsuits that allege Johnson & Johnson‘s baby powder and other talc products caused cancer. The decision is part…
[ad_1] The Janssen Johnson & Johnson COVID-19 vaccine. Allen J. Schaben | Los Angeles Times | Getty Images International Covid vaccine sales helped spark Johnson & Johnson‘s revenue and earnings beat on Tuesday, but the company said it expects no sales from the shot moving forward. “Regarding our Covid-19 vaccine, we do not anticipate material…
[ad_1] Johnson & Johnson shares fell Tuesday after the company reported adjusted earnings and revenue that topped Wall Street’s expectations, but lowered its sales guidance for its pharmaceutical business. J&J, whose financial results are considered a bellwether for many health companies, said its sales during the quarter grew 5.6% over the same quarter last year. related…
[ad_1] Johnson & Johnson (JNJ) before-the-bell Tuesday reported a strong first quarter, with sales up more than 5.5% and earnings eking out an annual increase. Shares of the Dow component and Club holding should not be losing 2.5% on these kinds of results. J & J’s first-quarter sales of $24.75 billion exceeded the Refinitv consensus…
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Dow drops with earnings in focus J & J decline misguided Starbucks undervalued? 1. Dow drops with earnings in focus Stocks fell Tuesday as Dow stocks Goldman Sachs (GS)…
